Deutsche Bank $1.75 billion notes offerings
The offerings included fixed-to-floating-rate and floating-rate eligible liabilities notes
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
UBS $1.25 billion senior notes offering
The investment-grade notes are due 2028
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
CRH $3 billion guaranteed notes offering
The investment-grade notes are due 2030, 2035 and 2055
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Banco Santander México $700 million senior notes offering
We advised Banco Santander México on the investment-grade offering
Amer Sports $1.05 billion follow-on offering
We advised Amer Sports on its SEC-registered offering
Aker BP $1.5 billion notes offering
The notes are due 2034 and 2054
NatWest Group $750 million contingent convertible Additional Tier 1 notes
We advised NatWest Group on the SEC-registered offering